Phase I AD-230 Pharmacokinetics Study, Chronic Liver Disease
Summary
The National Library of Medicine's ClinicalTrials.gov registered NCT07521241, a Phase I study evaluating the pharmacokinetics of investigational drug AD-230 in patients with chronic liver disease. The trial collects PK parameters to characterize drug absorption, distribution, metabolism, and excretion in this population. This registry entry documents the study's design, eligibility criteria, and investigator information for public transparency.
What changed
ClinicalTrials.gov published registration NCT07521241 for a Phase I pharmacokinetics study of investigational drug AD-230 in patients with chronic liver disease. The registry entry includes study objectives, eligibility criteria, endpoints, and participating investigator sites. As a public registry requirement under FDA regulations, this entry ensures transparency for clinical research involving human subjects.
Pharmaceutical sponsors conducting early-phase clinical research should ensure their trial registrations remain current and accurately reflect protocol amendments. Clinical investigators reviewing this entry should confirm institutional review board approval status and assess alignment with institutional drug development programs.
What to do next
- Monitor ClinicalTrials.gov for study updates
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NLM.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.